Turn Therapeutics (TTRX) Gains from Investment Securities (2024 - 2026)

Turn Therapeutics has reported Gains from Investment Securities for 3 years, with the latest figure at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities changed N/A year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (changed N/A YoY), and the FY2025 full-year result was $40030.0, down 97.62% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at $1.9 million, up from $40030.0 in the prior quarter.
• The five-year high for Gains from Investment Securities was $1.9 million in Q1 2026, with the low at $40030.0 in Q4 2025.
• Average Gains from Investment Securities over 3 years is $1.3 million, with a median of $1.7 million recorded in 2024.
• Peak annual rise in Gains from Investment Securities reached 97.62% in 2025, while the deepest fall reached 97.62% in 2025.
• Tracing TTRX's Gains from Investment Securities over 3 years: stood at $1.7 million in 2024, then tumbled by 97.62% to $40030.0 in 2025, then surged by 4751.82% to $1.9 million in 2026.
• The last three Gains from Investment Securities figures came in at $1.9 million (Q1 2026), $40030.0 (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.

Peer Comparison